These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36189794)

  • 1. Melanocortin 4 receptor agonism enhances sexual brain processing in women with hypoactive sexual desire disorder.
    Thurston L; Hunjan T; Mills EG; Wall MB; Ertl N; Phylactou M; Muzi B; Patel B; Alexander EC; Suladze S; Modi M; Eng PC; Bassett PA; Abbara A; Goldmeier D; Comninos AN; Dhillo WS
    J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.
    Thurston L; Hunjan T; Ertl N; Wall MB; Mills EG; Suladze S; Patel B; Alexander EC; Muzi B; Bassett PA; Rabiner EA; Bech P; Goldmeier D; Abbara A; Comninos AN; Dhillo WS
    JAMA Netw Open; 2022 Oct; 5(10):e2236131. PubMed ID: 36287566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.
    Mills EG; Ertl N; Wall MB; Thurston L; Yang L; Suladze S; Hunjan T; Phylactou M; Patel B; Muzi B; Ettehad D; Bassett PA; Howard J; Rabiner EA; Bech P; Abbara A; Goldmeier D; Comninos AN; Dhillo WS
    JAMA Netw Open; 2023 Feb; 6(2):e2254313. PubMed ID: 36735255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural bases of hypoactive sexual desire disorder in women: an event-related FMRI study.
    Bianchi-Demicheli F; Cojan Y; Waber L; Recordon N; Vuilleumier P; Ortigue S
    J Sex Med; 2011 Sep; 8(9):2546-59. PubMed ID: 21718449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bremelanotide for Treatment of Female Hypoactive Sexual Desire.
    Edinoff AN; Sanders NM; Lewis KB; Apgar TL; Cornett EM; Kaye AM; Kaye AD
    Neurol Int; 2022 Jan; 14(1):75-88. PubMed ID: 35076581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.
    Kingsberg SA; Simon JA
    J Womens Health (Larchmt); 2020 Aug; 29(8):1101-1112. PubMed ID: 32460605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Pfaus JG; Sadiq A; Spana C; Clayton AH
    CNS Spectr; 2022 Jun; 27(3):281-289. PubMed ID: 33455598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
    Diamond LE; Earle DC; Heiman JR; Rosen RC; Perelman MA; Harning R
    J Sex Med; 2006 Jul; 3(4):628-638. PubMed ID: 16839319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
    Kingsberg SA; Clayton AH; Portman D; Williams LA; Krop J; Jordan R; Lucas J; Simon JA
    Obstet Gynecol; 2019 Nov; 134(5):899-908. PubMed ID: 31599840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Pyke RE; Clayton AH
    J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J; Simon J; Dattani D; Taylor L; Kimura T; Garcia M; Lesko L; Pyke R;
    J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA; Thorp J; Millheiser L
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [No Abstract]   [Full Text] [Related]  

  • 17. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
    Parish SJ; Hahn SR
    Sex Med Rev; 2016 Apr; 4(2):103-120. PubMed ID: 27872021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.
    Simon JA; Kingsberg SA; Portman D; Jordan R; Lucas J; Sadiq A; Krop J; Clayton AH
    J Womens Health (Larchmt); 2022 Mar; 31(3):391-400. PubMed ID: 35230162
    [No Abstract]   [Full Text] [Related]  

  • 20. Bremelanotide: First Approval.
    Dhillon S; Keam SJ
    Drugs; 2019 Sep; 79(14):1599-1606. PubMed ID: 31429064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.